6 weeks: 3 vials use 6 mL total
Tailored Dosing : Dosages are adjusted based on the patients needs and response, often starting lower and increasing gradually to minimize side effects
Acknowledgements This work was supported in part by the German Research Foundation (DFG, PAK816) and the German Federal Ministry of Education and Research (BMBF, grant number 03Z22DN12)
Get expert
For most parameters, assessments should be conducted at baseline, 3 months, and then every 6 to 12 months, depending on individual risk and treatment type (70, 71)
Semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound) have shown remarkable clinical results, with many patients losing 15 to 20 percent or more of their body weight under proper medical supervision